ODTX
Odyssey Therapeutics, Inc.
20.99
+0.99 (+4.95%)
52w low 15.10
29.05 high
42.2% of range
Financial Analysis
| (USD) | Dec 25 | Mar 26 | Jun 26 | Sep 26 | Trend |
|---|---|---|---|---|---|
| Cash & Equivalents | 41.69M | 35.72M | 82.03M | 80.64M | |
| Current Assets | 190.66M | 185.10M | 321.46M | 337.80M | |
| Net PP&E | 26.01M | 24.48M | 21.92M | 20.76M | |
| Total Assets | 269.79M | 229.07M | 483.85M | 438.10M | |
| Current Liabilities | 26.48M | 22.21M | 28.30M | 26.10M | |
| Total Debt | 27.11M | 26.13M | 24.82M | 23.48M | |
| Total Liabilities | 758.07M | 752.76M | 62.63M | 62.33M | |
| Retained Earnings | -568.14M | -606.40M | -659.19M | -712.25M | |
| Shareholders Equity | -488.28M | -523.69M | 421.22M | 375.77M | |
| Working Capital | 164.18M | 162.89M | 293.17M | 311.70M | |
| Shares Outstanding | 47.17M | 47.17M | 47.89M | 48.07M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--